Yunkang and DeepSeek Drive AI Innovation in Healthcare
Advertisements
On February 14, 2025, Yunkang Group made a significant stride towards modernizing healthcare by officially integrating with DeepSeek. This move not only marks a comprehensive deployment of the group's digital platform but also introduces its first artificial intelligence-powered assistant, “Xiao Yun”. As a dominant player in the medical diagnostics and operational services sector in China, Yunkang aims to enhance its service quality and efficiency through the synergistic power of AI technologies, especially in response to the escalating health demands from its clientele.
Innovating Healthcare through Four Key Scenarios
The partnership between Yunkang and DeepSeek illustrates a deep fusion of AI into the entire spectrum of medical testing services. By establishing a comprehensive smart medical diagnostic solution that spans from "sample collection" to "report delivery," this collaboration is positioned to significantly enhance both the efficiency of diagnostics and the quality of service provided. The integration will focus initially on four pivotal areas: precise diagnostic capabilities, the creation of robust knowledge databases, enchanced service delivery, and management of operational data. This initiative is set to revolutionize the healthcare sector by paving the way for a comprehensive transformation towards intelligent systems. “Xiao Yun,” the first AI assistant launched, aims to streamline medical testing services, providing users with an experience that is not only more convenient but also highly efficient.
The incorporation of DeepSeek into Yunkang's operations signifies a crucial step in the latter's journey towards digital transformation. With innovative applications of AI technology, Yunkang is set to extend superior quality, more efficient, and cost-effective diagnostic solutions to patients, doctors, and partners alike.
Yunkang's Proactive Approach to AI Technology
The exploration of AI within the medical sector by Yunkang is not a new endeavor; rather, it has been developing for several years now. Making strides with advancements in cloud computing, 5G technology, big data, and artificial intelligence, Yunkang has successfully established platforms such as the 5G-enabled remote digital pathology diagnostic platform and the AI-driven pathological analysis data platform. These innovations showcase a clear commitment to merging technology with healthcare practices to drive better outcomes.
Furthermore, leveraging open-source models like DeepSeek, Yunkang is actively developing its large-scale models, fully embedding them within its collaborative networks across over 450 laboratories nationwide. Spanning more than 31 provinces and involving upwards of 1,500 healthcare networks, Yunkang collaborates with thousands of community health service centers and primary healthcare institutions, backed by an extensive professional workforce comprising medical personnel and researchers. This robust knowledge base supports the development of large models aimed at delving into healthcare service needs, fostering innovation in products and technology to create more precise, reliable, and accessible medical services.
With the debut of “Xiao Yun”, Yunkang takes AI technology application to a new height. This innovation not only enhances internal operational efficiency but also optimizes the level of intelligent service provided to external customers, wholeheartedly driving forward the innovative application of “AI + Healthcare” while providing essential technological support for empowering healthcare institutions at every level.
Through the integration of DeepSeek, Yunkang aims to achieve a holistic overhaul in medical testing and diagnostics. The value of this innovation transcends mere cost reduction and efficiency improvement; it also drives the healthcare industry toward a “data + AI-driven” transformation, providing pivotal support for the development of new productive forces under the Healthy China strategy.